Ahmedah H, Basheer H, Almazari I, Amawi K
Cancer Treat Res. 2024; 191:1-32.
PMID: 39133402
DOI: 10.1007/978-3-031-55622-7_1.
Bankier A, MacMahon H, Colby T, Gevenois P, Goo J, Leung A
Radiology. 2024; 310(2):e232558.
PMID: 38411514
PMC: 10902601.
DOI: 10.1148/radiol.232558.
Wang A, Gupta A, Grimm M, Pressburger D, Sparrow B, Richey J
Inhal Toxicol. 2023; 35(7-8):214-229.
PMID: 37339372
PMC: 11059106.
DOI: 10.1080/08958378.2023.2220735.
Wang A, Gupta A, Grimm M, Pressburger D, Sparrow B, Richey J
Inhal Toxicol. 2023; 35(7-8):201-213.
PMID: 37339371
PMC: 11062073.
DOI: 10.1080/08958378.2023.2220737.
Wu L, Yoshihara K, Yun H, Karim S, Shokri N, Zaeimi F
Int J Mol Sci. 2023; 24(5).
PMID: 36901697
PMC: 10001510.
DOI: 10.3390/ijms24054264.
Applying Existing Particle Paradigms to Inhaled Microplastic Particles.
Wright S, Borm P
Front Public Health. 2022; 10:868822.
PMID: 35712293
PMC: 9197419.
DOI: 10.3389/fpubh.2022.868822.
Prevention of Occupational Hazards Due to Asbestos Exposure in Dentistry. A Proposal from a Panel of Experts.
Anaya-Aguilar C, Bravo M, Magan-Fernandez A, Del Castillo-Salmeron R, Rodriguez-Archilla A, Montero J
Int J Environ Res Public Health. 2022; 19(6).
PMID: 35328844
PMC: 8955252.
DOI: 10.3390/ijerph19063153.
NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases.
Franko A, Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V
J Med Biochem. 2020; 39(1):91-99.
PMID: 32549782
PMC: 7282242.
DOI: 10.2478/jomb-2019-0025.
Asbestos-related pleural disease.
Geller S, Campos F
Autops Case Rep. 2019; 3(2):59-61.
PMID: 31528609
PMC: 6673680.
DOI: 10.4322/acr.2013.019.
Macrophage Recognition of Crystals and Nanoparticles.
Nakayama M
Front Immunol. 2018; 9:103.
PMID: 29434606
PMC: 5796913.
DOI: 10.3389/fimmu.2018.00103.
Histamine as an emergent indoor contaminant: Accumulation and persistence in bed bug infested homes.
DeVries Z, Santangelo R, Barbarin A, Schal C
PLoS One. 2018; 13(2):e0192462.
PMID: 29432483
PMC: 5809050.
DOI: 10.1371/journal.pone.0192462.
Accelerated cell cycle progression of human regulatory T cell-like cell line caused by continuous exposure to asbestos fibers.
Lee S, Matsuzaki H, Maeda M, Yamamoto S, Kumagai-Takei N, Hatayama T
Int J Oncol. 2016; 50(1):66-74.
PMID: 27878235
PMC: 5182008.
DOI: 10.3892/ijo.2016.3776.
Mortality in a combined cohort of uranium enrichment workers.
Yiin J, Anderson J, Daniels R, Bertke S, Fleming D, Tollerud D
Am J Ind Med. 2016; 60(1):96-108.
PMID: 27753121
PMC: 5708885.
DOI: 10.1002/ajim.22668.
Occupational exposures and lung cancer risk among Minnesota taconite mining workers.
Allen E, Alexander B, MacLehose R, Nelson H, Ryan A, Ramachandran G
Occup Environ Med. 2015; 72(9):633-9.
PMID: 25977445
PMC: 4537827.
DOI: 10.1136/oemed-2015-102825.
Current investigations into the genotoxicity of zinc oxide and silica nanoparticles in mammalian models in vitro and in vivo: carcinogenic/genotoxic potential, relevant mechanisms and biomarkers, artifacts, and limitations.
Kwon J, Koedrith P, Seo Y
Int J Nanomedicine. 2015; 9 Suppl 2:271-86.
PMID: 25565845
PMC: 4279763.
DOI: 10.2147/IJN.S57918.
The risk of lung cancer after cessation of asbestos exposure in construction workers using pleural malignant mesothelioma as a marker of exposure.
Jarvholm B, Astrom E
J Occup Environ Med. 2014; 56(12):1297-301.
PMID: 25479300
PMC: 4243788.
DOI: 10.1097/JOM.0000000000000258.
Environmentally related diseases and the possibility of valuation of their social costs.
Hajok I, Marchwinska E, Dziubanek G, Kuraszewska B, Piekut A
ScientificWorldJournal. 2014; 2014:284072.
PMID: 25374934
PMC: 4211139.
DOI: 10.1155/2014/284072.
CREB-induced inflammation is important for malignant mesothelioma growth.
Westbom C, Shukla A, MacPherson M, Yasewicz E, Miller J, Beuschel S
Am J Pathol. 2014; 184(10):2816-27.
PMID: 25111229
PMC: 4188864.
DOI: 10.1016/j.ajpath.2014.06.008.
Genes involved in innate immunity associated with asbestos-related fibrotic changes.
Kukkonen M, Vehmas T, Piirila P, Hirvonen A
Occup Environ Med. 2013; 71(1):48-54.
PMID: 24142982
PMC: 3888604.
DOI: 10.1136/oemed-2013-101555.
Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenografts.
Macura S, Steinbacher J, MacPherson M, Lathrop M, Sayan M, Hillegass J
BMC Cancer. 2013; 13:400.
PMID: 24024776
PMC: 3846908.
DOI: 10.1186/1471-2407-13-400.